Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.

Inflamm Bowel Dis · 2025 · PMC11700895 · PMID 38507608

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < .001actually significant

Even fewer ADRs related to the anti-TNF therapy occurred in the intervention group after month 0, leading to a highly significant result favoring the intervention group (0.08 ± 0.10 vs 0.19 ± 0.19 [mean ± standard deviation] ADR/patient/month; P < .001; Figure 2B ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.